Senior insider sale
Executive Chairman at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$59.92M
137.07K shares
What this filing means
LEIDEN JEFFREY M plans to sell 137.07K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $59.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/3/2025ACC: 0001950047-25-009722
DirectorOfficer· Executive Chairman
Since Feb 2026
137.07K
Shares to sell
$59.92M
Approx. market value
63.78K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/3/2025
63.78KTotal acquired63.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/3/2025 | Exercise of Stock Options Cash | 63.78K | — |
| Total | 63.78K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
53.60K
Market value
$23.62M
11/14/2025
—Completed
Units to sell
19.69K
Market value
$8.67M
11/13/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
63.78K
Market value
$27.63M
12/3/2025
Total
Units
137.07K
Value
$59.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/14/2025 | 53.60K | $23.62M | — | Completed |
11/13/2025 | 19.69K | $8.67M | — | Completed |
| Planned — Approximate Date | ||||
12/3/2025 | 63.78K | $27.63M | NASDAQ | Planned |
| Total | 137.07K | $59.92M | ||